Tag: Novartis gene therapy investment
Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment
Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not only the gene therapy startup itself but also its drug...